S3 Collective DEA's Decision-making Process The Drug Enforcement Administration (DEA) is the federal agency responsible for enforcing the controlled substances laws and regulations of the United States. In the context of cannabis rescheduling, ... Policy & Regulatory Framework
S3 Collective Cannabis' Current Schedule I Status Currently, cannabis is classified as a Schedule I substance under the Controlled Substances Act in the United States. This classification is designated for drugs that are considered to have a high pot... Policy & Regulatory Framework
S3 Collective Research Limitations Due to Scheduling The Schedule I classification of cannabis imposes significant limitations on research. Researchers face bureaucratic and regulatory hurdles that complicate access to cannabis for study purposes. This ... Policy & Regulatory Framework
S3 Collective FDA's Criteria for Scheduling The Food and Drug Administration (FDA) utilizes a set of specific criteria to evaluate substances for drug scheduling. These criteria are based on scientific and medical evidence and include factors s... Policy & Regulatory Framework
S3 Collective Role of Advocacy Groups Advocacy groups play a significant role in the cannabis rescheduling debate, representing a range of perspectives and interests. Pro-cannabis groups advocate for legalization and rescheduling, highlig... Policy & Regulatory Framework
S3 Collective Potential for Federal-State Collaboration The rescheduling of cannabis could lead to increased federal-state collaboration in regulating cannabis. This cooperation is essential for creating a consistent and effective regulatory framework that... Policy & Regulatory Framework
S3 Collective Challenges in Law Enforcement Training and Practices The rescheduling of cannabis would necessitate changes in law enforcement training and practices. Officers would need updated training on cannabis laws, including detection of impairment, enforcement ... Policy & Regulatory Framework
